| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mirchandani Sanjay | President & CEO, Director | 1 COMMVAULT WAY, TINTON FALLS | /s/ Danielle Abrahamsen, Attorney-in-Fact | 19 May 2025 | 0001765820 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVLT | Common Stock | Award | $0 | +34K | +8.19% | $0.00 | 449K | 15 May 2025 | Direct | F1 |
| transaction | CVLT | Common Stock | Award | $0 | +25.5K | +5.68% | $0.00 | 475K | 15 May 2025 | Direct | F2 |
| transaction | CVLT | Common Stock | Award | $0 | +25.5K | +5.37% | $0.00 | 500K | 15 May 2025 | Direct | F3 |
| transaction | CVLT | Common Stock | Sale | -$2.65M | -14.9K | -2.97% | $178.41 | 485K | 16 May 2025 | Direct | F4, F5 |
| transaction | CVLT | Common Stock | Sale | -$17.6K | -100 | -0.02% | $175.98 | 485K | 16 May 2025 | Direct | |
| transaction | CVLT | Common Stock | Sale | -$422K | -2.37K | -0.49% | $177.67 | 483K | 16 May 2025 | Direct | F6 |
| transaction | CVLT | Common Stock | Sale | -$71.7K | -400 | -0.08% | $179.30 | 483K | 16 May 2025 | Direct | F7 |
| transaction | CVLT | Common Stock | Sale | -$18K | -100 | -0.02% | $179.95 | 482K | 16 May 2025 | Direct | |
| transaction | CVLT | Common Stock | Sale | -$4.91K | -27 | -0.01% | $181.69 | 482K | 16 May 2025 | Direct | |
| transaction | CVLT | Common Stock | Award | $0 | +21.6K | +4.49% | $0.00 | 504K | 16 May 2025 | Direct | F8 |
| transaction | CVLT | Common Stock | Award | $0 | +13K | +2.57% | $0.00 | 517K | 16 May 2025 | Direct | F9 |
| transaction | CVLT | Common Stock | Award | $0 | +13K | +2.51% | $0.00 | 530K | 19 May 2025 | Direct | F10 |
| transaction | CVLT | Common Stock | Sale | -$510K | -2.92K | -0.55% | $174.68 | 527K | 19 May 2025 | Direct | F11 |
| transaction | CVLT | Common Stock | Sale | -$1.55M | -8.86K | -1.68% | $175.59 | 518K | 19 May 2025 | Direct | F12 |
| transaction | CVLT | Common Stock | Sale | -$995K | -5.64K | -1.09% | $176.56 | 513K | 19 May 2025 | Direct | F13 |
| transaction | CVLT | Common Stock | Sale | -$152K | -859 | -0.17% | $177.19 | 512K | 19 May 2025 | Direct | F14 |
| transaction | CVLT | Common Stock | Sale | -$4.58M | -26.1K | -5.1% | $175.74 | 486K | 19 May 2025 | Direct | F4 |
| transaction | CVLT | Common Stock | Sale | -$1.95K | -11 | 0% | $177.00 | 486K | 19 May 2025 | Direct | F4, F15 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The common stock is being granted as restricted stock units and is subject to a 3-year vesting schedule, as follows: 1/3 on the first anniversary of the grant with the remaining portion vesting in equal quarterly installments thereafter. |
| F2 | The common stock is being granted as performance share units (PSUs), 1/3 of which will vest, on each of the first, second and third anniversaries of the grant date of the award, if on such dates the Company's total shareholder return satisfies specified benchmarks relative to Russell 3000 index. |
| F3 | The common stock is being granted as performance share units (PSUs) which will vest over a three year period based on the Company's achievement of certain financial performance metrics. |
| F4 | Represents shares automatically sold solely to satisfy tax withholding obligations of reporting person on vesting of restricted stock. Proceeds from the sale were submitted to the Internal Revenue Service. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.15 and $178.41, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.32 and $178.01, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.80 and $179.60, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F8 | Represents additional shares issued in connection with the Company's total shareholder return for fiscal year 2025 satisfying specified benchmarks relative to the Russell 3000 index pursuant to the terms of an award granted on May 15, 2024. |
| F9 | Represents additional shares issued in connection with the Company's total shareholder return for fiscal year 2025 satisfying specified benchmarks relative to the Russell 3000 index pursuant to the terms of an award granted on May 15, 2023. |
| F10 | Represents additional shares issued in connection with the Company's total shareholder return for fiscal year 2025 satisfying specified benchmarks relative to the Russell 3000 index pursuant to the terms of an award granted on May 16, 2022. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.01 and $174.91, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.05 and $176.03, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.06 and $177.03, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.11 and $177.33, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F15 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.92 and $177.11, inclusive. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |